The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
Yong Ling,Zhi-You Hao,Dong Liang,Chun-Lei Zhang,Yan-Fei Liu,Yan Wang
DOI: https://doi.org/10.2147/DDDT.S329547
2021-10-12
Abstract:Yong Ling, 1 Zhi-You Hao, 2 Dong Liang, 3 Chun-Lei Zhang, 4 Yan-Fei Liu, 5 Yan Wang 6, 7 1 Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China; 2 School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China; 3 State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, Guangxi, People's Republic of China; 4 State Key Laboratory of Natural Medicines and Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China; 5 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; 6 HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan; 7 Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China Correspondence: Yan Wang HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan Tel +92 21 111-222-292 ext 164 Fax +92 21 34819018-9 Email Pyridine-based ring systems are one of the most extensively used heterocycles in the field of drug design, primarily due to their profound effect on pharmacological activity, which has led to the discovery of numerous broad-spectrum therapeutic agents. In the US FDA database, there are 95 approved pharmaceuticals that stem from pyridine or dihydropyridine, including isoniazid and ethionamide (tuberculosis), delavirdine (HIV/AIDS), abiraterone acetate (prostate cancer), tacrine (Alzheimer's), ciclopirox (ringworm and athlete's foot), crizotinib (cancer), nifedipine (Raynaud's syndrome and premature birth), piroxicam (NSAID for arthritis), nilvadipine (hypertension), roflumilast (COPD), pyridostigmine (myasthenia gravis), and many more. Their remarkable therapeutic applications have encouraged researchers to prepare a larger number of biologically active compounds decorated with pyridine or dihydropyridine, expandeing the scope of finding a cure for other ailments. It is thus anticipated that myriad new pharmaceuticals containing the two heterocycles will be available in the forthcoming decade. This review examines the prospects of highly potent bioactive molecules to emphasize the advantages of using pyridine and dihydropyridine in drug design. We cover the most recent developments from 2010 to date, highlighting the ever-expanding role of both scaffolds in the field of medicinal chemistry and drug development. Keywords: nitrogen heterocycles, pharmaceuticals, bioactive compounds, current trend, substituent effect Heterocycles are intricately woven into basic processes of life and play a crucial role in the pharmaceutical and agrochemical industries. 1 In terms of pharmacological, physicochemical, pharmacokinetic, and toxicological properties, heterocyclic structures are found in >90% of newly synthesized and marketed drugs. 2 Medicinal chemistry has evolved from an empirical practice involving the synthesis of novel substances and then gauging their biological activity. 3 A plethora of synthetic compounds with heterocyclic structural frameworks have been identified — with privileged six-membered N-containing pyridine and dihydropyridine rings — linked to a diverse range of bioactivity. 4–7 In the realm of six-membered heterocyclic structures, they have unique and interesting characteristics. Owing to their therapeutic potential, medicinal chemists have recently become drawn toward scaffolds in order to synthesize a wide range of novel bioactive molecules. 8 In pharmaceutical targets, pyridine and its precursor molecule dihydropyridine are among the most prevalent structural units. 9,10 In plants, they are mostly found in the alkaloids. 11 In biological systems, redox reactions of nicotinamide adenine dinucleotide (NAD) reduces its pyridine ring into dihydropyridine, rendering NADH. Similar redox reactions are also present in anabolic reactions involving NAD phosphate (NADP + /NADPH) interconversion. 12 A glance at the US Food and Drug Administration (FDA) database reveals that pyridine- and dihydropyridine-containing drugs constitute nearly 14% and 4% of N -heterocyclic drugs approved by the agen -Abstract Truncated-